2nd Quarter - Report

CHRISTY ELLERBEE CONSULTING, LLC for INDIVIOR, PLC (FKA RECKITT BENCKISER PHARMACEUTICALS, INC.)

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Pharmaceutical issues relevant to Indivior, PLC; S. 1455 TREAT Act.

LobbyistCovered position, as disclosed
CHRISTY ELLERBEE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1455 (114th)

Pharmacy PHA

Pharmaceutical issues relevant to Indivior, PLC; S. 1455 TREAT Act.

LobbyistCovered position, as disclosed
CHRISTY ELLERBEE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1455 (114th)

Health Issues HCR

Pharmaceutical issues relevant to Indivior, PLC; S. 1455 TREAT Act.

LobbyistCovered position, as disclosed
CHRISTY ELLERBEE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1455 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.